Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center
Advertisement
Articles by Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center
Advertisement
Latest Updated Articles
Perioperative Therapy: ASCO 2020 Data UpdatesPublished: August 13th 2020 | Updated:
Metastatic HR+ Breast Cancer UpdatesPublished: August 13th 2020 | Updated:
Metastatic Triple-Negative Breast Cancer Ongoing TrialsPublished: August 13th 2020 | Updated:
ASCO 2020 Data Updates: Metastatic HER2+ Breast CancerPublished: August 13th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Meta-Analysis Characterizes Nivolumab/Ipilimumab Hyperprogression in Renal Medullary Carcinoma
5